Dr. Dante Salvador , MD, PhD

Montilla, Precious Juzenda, Aquino, Camilo Oliver, Cunanan, Elaine, Encarnacion, Patrick James, Ong-Garcia, Helen, Llanes, Elmer Jasper, Orolfo, Diana Dalisay, Permejo, Chito, Taneo, Mary Joy, Villanueva, Anthony Russell, Salvador, Dante, & Añonuevo, John. (2025). Cost-utility analysis of empagliflozin for heart failure in the Philippines [Journal-article]. Journal of Medical Economics, 28(1), 157–167. https://doi.org/10.1080/13696998.2024.2447180

Salvador, Dante, Bano, Arjola, Wehrli, Faina, Gonzalez-Jaramillo, Valentina, Laimer, Markus, Hunziker, Lukas, & Muka, Taulant. (2023). Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study [Journal-article]. Cardiovascular Diabetology, 22(1). https://doi.org/10.1186/s12933-023-01903-7

Glisic, M., Raguindin, P. F., Gemperli, A., Taneri, P. E., Salvador, D., Voortman, T., Marques Vidal, P., Papatheodorou, S. I., Kunutsor, S. K., Bano, A., Ioannidis, J. P. A., & Muka, T. (2023). A 7-Step Guideline for Qualitative Synthesis and Meta-Analysis of Observational Studies in Health Sciences. Public Health Reviews, 44. https://doi.org/10.3389/phrs.2023.1605454

Tuleja, A., Salvador, D., Muka, T., Bernhard, S., Lenz, A., Baumgartner, I., & Schindewolf, M. (2022). Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia. Blood Advances, 6(10), 3114–3125. https://doi.org/10.1182/bloodadvances.2022007017

Salvador, D. B., Gamba, M. R., Gonzalez-Jaramillo, N., Gonzalez-Jaramillo, V., Raguindin, P. F. N., Minder, B., Gräni, C., Wilhelm, M., Stettler, C., Doria, A., Franco, O. H., Muka, T., & Bano, A. (2022). Diabetes and Myocardial Fibrosis: A Systematic Review and Meta-Analysis. JACC: Cardiovascular Imaging, 15(5), 796–808. https://doi.org/10.1016/j.jcmg.2021.12.008